Webinar

Osteoblast Too Lazy or Just Insulin Resistant

8th February, 2021
04:00 PM
Osteoblast Too Lazy or Just Insulin Resistant

Overview

Insulin and its downstream signaling cascade regulate osteoclast and osteoblast development, essential for postnatal bone formation and turnover. Insulin signaling regulates osteoblast bone production and osteoclast bone resorption, although largely in osteoblasts. Impaired osteoblastic insulin signaling affects osteoblast proliferation, differentiation, and survival, lowering bone quality. Insulin, MAPK, and PI3K/Akt play key roles in bone cell development, function, and survival. Osteoblastic insulin signaling controls bone development and turnover and is necessary for energy metabolism.

  Speakers

Dr. S. K. Singh

Dr. S. K. Singh

Professor and Head, Department of Endocrinology and Metabolism, Institute of Medical Science, Banaras, Hindu University, Varanasi


Dr. Rajesh R. Nawalkar

Dr. Rajesh R. Nawalkar

Consultant - Joint Replacement Surgery in Jaslok Hospital, Mumbai


Dr. Kamini A. Rao

Dr. Kamini A. Rao

Founder and Medical Director of Milann is a pioneer in the field of Assisted Reproduction in India